Tempest Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Tempest Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Tempest Therapeutics Inc
Rating: 2.12933325
Author: Trendlyne DVM scores

about

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic pr...

9.22 -0.03 (-0.32%)

2148.78% Gain from 52W Low

21,059

XNAS Volume

XNAS 20 Aug, 2025 12:09 PM (EDT)

Not Eligible

Expensive Valuation

5.8 / 100

Technically Bullish

79.3 / 100

No estimates available

Tempest Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Tempest Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic pr...

2148.78% Gain from 52W Low

SWOT Analysis

Tempest Therapeutics Inc Live Price Chart